about
Creatine, L-carnitine, and ω3 polyunsaturated fatty acid supplementation from healthy to diseased skeletal muscle.Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in GermanyComparison of mutation profiles in the Duchenne muscular dystrophy gene among populations: implications for potential molecular therapies."Watching time tick by…": Decision making for Duchenne muscular dystrophy trialsPotential therapeutic role of L-carnitine in skeletal muscle oxidative stress and atrophy conditions.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Innovating therapies for muscle diseases.
@en
type
label
Innovating therapies for muscle diseases.
@en
prefLabel
Innovating therapies for muscle diseases.
@en
P1476
Innovating therapies for muscle diseases.
@en
P2093
Gert-Jan Van Ommen
Jean-Claude Kaplan
P304
P356
10.1016/B978-0-444-59565-2.00020-4
P577
2013-01-01T00:00:00Z